Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC)

NCT00102804 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

663

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Placebo
OTHER: Best Supportive Care

Sponsor

Eli Lilly and Company